PubMed · 2007 · 57 citations · 12 references
Life SciencesImmunologyOncologyCell SignalingInflammationTumor MicroenvironmentCytokine BiologyCytokine RegulationCytokine SignalingCytokine-based TherapyInflammatory Cell SignalingInflammatory SignalingChitosanChitosan OligosaccharidesChitosan-based BiomaterialsNitric OxideNitric Oxide ProductionNitric Oxide SignalingPretreatmentProinflammatory Cytokine Modulation
The effect of chitosan oligosaccharide (COS, 1 kDa <MW<3 kDa) on proinflammatory cytokines-induced nitric oxide (NO) production and invasiveness of human colorectal adenocarcinoma HT-29 cells was investigated. COS (0.1-5mg/ ml) suppressed the NO production induced by proinflammatory cytokines (100 U/ml IFN-gamma, 10 ng/ml IL-1alpha, and 25 ng/ml TNF-alpha) in HT-29 cells. Inducible nitric oxide synthase (iNOS) expression induced by these cytokines was inhibited by COS. COS pretreatment inhibited the invasiveness of cytokines-treated HT-29 cells through Matrigel-coated membrane in a dose-dependent manner. COS also inhibited cytokines-induced matrix metalloproteinase (MMP)-2 activity. This study shows that proinflammatory cytokines induce NO production, iNOS expression, and invasiveness of human colorectal adenocarcinoma HT-29 cells. COS pretreatment inhibited cytokines-mediated NO production, iNOS expression, and invasiveness of HT-29 cells. These results provide sufficient information for the further development of COS as an antitumor metastatic agent for the treatment of colon cancer.
12
Kay Friedrichs, Paloma Ruiz, F. Franke et al. · PubMed · 1995 · 196 citations
Medicine, Cancer Biology, Oncology +11
Phenotypic relationships of prostatic intraepithelial neoplasia to invasive prostatic carcinoma.
Raymond B. Nagle, M K Brawer, John M. Kittelson et al. · PubMed · 1991 · 131 citations